IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)

BACKGROUND: Certain immunoglobulins (Ig) are proposed to have protective functions in atherosclerosis. OBJECTIVES: We tested whether serum levels of IgG and IgM autoantibodies against malondialdehyde low density lipoprotein (MDA-LDL) are associated with clinical coronary heart disease (CHD) and unfa...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Berg, Victor J., Haskard, Dorian O., Fedorowski, Artur, Hartley, Adam, Kardys, Isabella, Caga-Anan, Mikhail, Akkerhuis, K. Martijn, Oemrawsingh, Rohit M., van Geuns, Robert Jan, de Jaegere, Peter, van Mieghem, Nicolas, Regar, Evelyn, Ligthart, Jurgen M.R., Umans, Victor A.W.M., Serruys, Patrick W., Melander, Olle, Boersma, Eric, Khamis, Ramzi Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197783/
https://www.ncbi.nlm.nih.gov/pubmed/30131305
http://dx.doi.org/10.1016/j.ebiom.2018.08.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197783/
https://www.ncbi.nlm.nih.gov/pubmed/30131305
http://dx.doi.org/10.1016/j.ebiom.2018.08.023

Ejemplares similares